Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index within the next 6 to 12 months [17]. Core Insights - The company reported a revenue of 2,407 million yuan for 2025, reflecting a year-on-year growth of 4.16%, and a net profit attributable to shareholders of 719 million yuan, which is a 10.77% increase year-on-year [4][5]. - The company has shown significant improvement in profitability, with a gross margin of 53.92% in 2025, up by 3.49 percentage points year-on-year, and a net profit margin of 29.88%, increasing by 1.79 percentage points year-on-year [6][7]. - The company is focusing on technological innovation in the dental medical field, launching new products and applications, and is optimistic about future growth despite current market challenges [12]. Summary by Relevant Sections Financial Performance - In 2025, the company achieved a revenue of 2,407 million yuan, with a projected revenue growth rate of 14% for 2026 [3][4]. - The net profit for 2025 was 719 million yuan, with an expected growth of 18% in 2026 [3][4]. - The earnings per share (EPS) for 2025 is projected at 0.82 yuan, with an increase to 0.96 yuan in 2026 [3][4]. Profitability Analysis - The company’s gross margin improved to 53.92% in 2025, driven by enhanced production efficiency and a favorable product mix [6][7]. - The net profit margin also increased, indicating better cost management and operational efficiency [7]. Operational Efficiency - Inventory turnover days decreased to 97.28 days, and accounts receivable turnover days improved to 63.33 days, reflecting better sales channel optimization and inventory management [8]. - The company’s operating cash flow reached 9.62 billion yuan, indicating a steady improvement in operational quality [8]. Research and Development - The company invested 164 million yuan in R&D in 2025, representing 6.81% of its revenue, and holds a significant number of patents, indicating a strong commitment to innovation [8][12]. Market Position and Growth Potential - The company is a leader in the color sorting machine industry, with a revenue of 1,753 million yuan in 2025, growing by 8.05% year-on-year [9]. - The dental medical segment, while currently facing challenges, is expected to recover, with the company continuing to invest in this area [12]. Future Outlook - The company anticipates a net profit of 846 million yuan in 2026, with a growth rate of 17.64%, and further growth projected for 2027 and 2028 [13]. - The demand for color sorting machines remains robust, and the dental sector is expected to provide long-term growth opportunities [13].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index in the next 6 to 12 months [17]. Core Insights - The company reported a revenue of 2.407 billion yuan for 2025, reflecting a year-on-year growth of 4.16%, and a net profit attributable to shareholders of 719 million yuan, up 10.77% year-on-year [4][5]. - The company has shown significant improvement in profitability, with a gross margin of 53.92%, an increase of 3.49 percentage points year-on-year, and a net profit margin of 29.88%, up 1.79 percentage points year-on-year [7]. - The company is focusing on technological innovation in the dental medical field, launching new products and applications, and is optimistic about future growth despite current market challenges [12]. Financial Performance Summary - Revenue and Profit Forecast: - 2024A: Revenue of 2.311 billion yuan, net profit of 649 million yuan - 2025A: Revenue of 2.407 billion yuan, net profit of 719 million yuan - 2026E: Revenue of 2.749 billion yuan, net profit of 846 million yuan - 2027E: Revenue of 3.112 billion yuan, net profit of 981 million yuan - 2028E: Revenue of 3.485 billion yuan, net profit of 1.127 billion yuan [3][14]. - Growth Rates: - Revenue growth rates are projected at -5% for 2024, 4% for 2025, and 14% for 2026, with net profit growth rates at -13% for 2024, 11% for 2025, and 18% for 2026 [3][14]. Operational Efficiency - The company has improved its inventory turnover days to 97.28 days, a decrease of 12.28 days year-on-year, and accounts receivable turnover days to 63.33 days, down 16.41 days year-on-year, indicating better sales channel optimization and cost control [8]. - The company’s R&D investment reached 164 million yuan in 2025, accounting for 6.81% of revenue, with a slight decrease of 0.09 percentage points year-on-year [8]. Market Position and Product Development - The color sorting machine segment continues to grow steadily, with revenue reaching 1.753 billion yuan in 2025, an increase of 8.05% year-on-year, and a gross margin of 54.26%, up 4.62 percentage points [9]. - The company is a pioneer in the domestic color sorting industry, focusing on innovation and expanding its product applications across various sectors [9]. Future Outlook - The company is optimistic about the dental medical market despite current downturns, with a projected revenue of 454 million yuan from medical equipment in 2025, although this represents a decline of 9.75% year-on-year [12]. - The introduction of the "Meiya Dental Health Digital Cloud Platform" aims to enhance operational efficiency and is expected to contribute to revenue growth as AI applications develop [13].